We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule.
- Authors
Baselga, José; Carbonell, Xavier; Castañeda-Soto, Noel-Jaime; Clemens, Michael; Green, Michael; Harvey, Vernon; Morales, Serafin; Barton, Claire; Ghahramani, Parviz
- Abstract
This phase II study investigated the efficacy, safety, and pharmacokinetics of trastuzumab monotherapy given as first-line treatment once every 3 weeks (3-weekly) in women with human epidermal growth factor receptor 2 (HER2) -positive metastatic breast cancer (MBC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 10, p2162
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.01.014